J.Jpn. Surg. Soc.
ISSN 1880-1129

[Abstract] [Full Text PDF] （in Japanese / 1543KB） [Members Only And Two Factor Auth.]

J.Jpn. Surg. Soc.. 100(3): 257-260, 1999

Feature topic

SURGICAL TREATMENT OF ADENOCARCINOMA IN BARRETT'S ESOPHAGUS AND PROGNOSIS

1) Department of Surgical Oncology, National Cancer Center Hospital, Tokyo, Japan
2) Department of Endoscopy, National Cancer Center Hospital, Tokyo, Japan
3) Pathology Division, National Cancer Center Research lnstitute, Tokyo, Japan

Yasuhiro Tsubosa1), Hiroshi Watanabe1), Houichi Katou1), Yuuji Tachimori1), Hhroyasu Igaki1), Hajime Yamaguchi2), Yukihiro Nakanishi3)

There is no consensus regarding the surgical approach to adenocarcinoma in Barrett’s esophagus. From 1980 to 1998, 8 patients with adenocarcinoma in Barrett’s esophagus were treated at the National Cancer Center Hospital. Seven patients underwent subtotal esophagectomy with extended lymph node dissection, and one transhiatal esophagogastrectomy with regional lymph node dissection. In 4 patients tumor invasion was limited within the submucosa and in 4 within the muscularis propria. Four of 8 patients had stage I disease. The 5-year survival rate for the 8 patients was 64.3％. Some reports have indicated that endoscopic survey for Barrett’s esophagus is important for early diagnosis.
We conclude that survival after esophagectomy for adenocarcinoma in Barrett’s esophagus is dependent on the method of operation, and that patients with early lesions may expect significantly better survival after extended lymph node dissection.

<< To previous pageTo next page >>

To read the PDF file you will need Adobe Reader installed on your computer.